RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

por Kruszewski, Adam M., Rao, Gautam, Tatomir, Alexandru, Hewes, Daniel, Tegla, Cosmin A., Cudrici, Cornelia D., Nguyen, Vingh, Royal, Walter, Bever, Christopher T., Rus, Violeta, Rus, Horea
Publicado en Exp Mol Pathol (2015)

Epigenetic modifications induced by RGC-32 in colon cancer

por Vlaicu, Sonia I., Tegla, Cosmin A., Cudrici, Cornelia D., Fosbrink, Matthew, Nguyen, Vingh, Azimzadeh, Philippe, Rus, Violeta, Chen, Hegang, Mircea, Petru A., Shamsuddin, Abulkalam, Rus, Horea
Publicado 2009